Clinical Trials Directory

Trials / Completed

CompletedNCT03705624

P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
907 (actual)
Sponsor
London School of Hygiene and Tropical Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In the current randomized trial, the investigators will test the ability of two experimental approaches to malaria infection management to reduce malaria transmission potential. Compounds in Saponé, Burkina Faso, will be randomized to 1 of 3 study arms: arm 1 - current standard of care with passively monitored malaria infections; arm 2 - standard of care plus enhanced community case management (CCM), comprising active weekly screening for fever, and detection and treatment of infections in fever positive individuals using conventional rapid diagnostic tests (RDTs); or arm 3 - standard of care and enhanced CCM, plus monthly screening and treatment (MSAT) using RDTs. The study will be conducted over approximately 18 months covering two high transmission seasons and the intervening dry season

Conditions

Interventions

TypeNameDescription
OTHEREnhanced Community Case Management (CCM)Enhanced Community Case Management for malaria (CCM) involving weekly active screening for fever using a research-grade thermometer by a trained health worker. A measured temperature ≥37.5°C or reported fever in the last 24 hours will prompt screening with a conventional rapid diagnostic test (RDT). RDT positive individuals will be treated with AL according to national guidelines
OTHERMonthly Screening and Treatment (MSAT)Monthly Screening and Treatment (MSAT) regardless of symptoms with a conventional RDT. Screening will be performed by research staff with 25-35 days between screening rounds; RDT positive individuals will be treated with AL according to national guidelines.

Timeline

Start date
2018-08-06
Primary completion
2020-02-14
Completion
2020-02-14
First posted
2018-10-15
Last updated
2020-02-28

Locations

1 site across 1 country: Burkina Faso

Source: ClinicalTrials.gov record NCT03705624. Inclusion in this directory is not an endorsement.